Demand for Remicade Biosimilar in USA Growth, Reve..

创建了一篇新文章

7 在

Demand for Remicade Biosimilar in USA Growth, Revenue Trends, Company Strategy Analysis By FMI | #demand for Remicade Biosimilar in USA

Demand for Remicade Biosimilar in USA Growth, Revenue Trends, Company Strategy Analysis By FMI

Demand for Remicade Biosimilar in USA Growth, Revenue Trends, Company Strategy Analysis By FMI

The U.S. Remicade biosimilar market is valued at USD 0.8 billion in 2025 and is projected to expand to USD 1.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.1% over the forecast period.

喜欢

评论

分享